Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
Harvard University · Massachusetts General Hospital · +6 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
989
total citations
- FWCI
- 88.43
- Percentile
- 100%
- References
- 55
Citations per year
Authors
30- ANAaron N. HataCorresponding
Harvard University, Massachusetts General Hospital
- MJMatthew J. Niederst
Harvard University, Massachusetts General Hospital
- HLHannah L. Archibald
Massachusetts General Hospital
- MGMaría Gomez‐Caraballo
Massachusetts General Hospital
- FMFaria M. Siddiqui
Massachusetts General Hospital
Topics & keywords
Topics
Keywords
- T790M
- Epidermal growth factor receptor
- EGFR inhibitors
- Biology
- Cancer research
- clone (Java method)
- Drug resistance
- Mutation
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.